… compared with continued ICS/bronchodilator therapy [67]. … care with long-acting
bronchodilators: COPD registry in … an increase in the risk of exacerbations or an increased risk of …

… We deemed the Sanchez 1992 trial to be at high risk of reporting bias as the authors only
reported outcome data for the nine out of 12 participants who had shown a previous response …

… It is caused mainly by exposure to inhaled irritants, … (post-bronchodilator FEV 1 /FVC [forced
vital capacity] ratio < 0.7, and FEV 1 < 80% predicted). With spirometry, there is some risk of …

… , and differences in lipophilicity/hydrophilicity of ICSs determine the risk of pneumonia in …
We firmly believe that individual molecules, regardless of whether they are bronchodilators or …

… of an association between inhaled corticosteroid therapy and an increased risk of cataract
formation is more controversial. Inhaled corticosteroids could reach the eye either by the …

… characteristics required by novel inhaled LABAs include 24 h bronchodilator effect in vivo …
risk of pneumonia (RR 1.67, 95% CI 1.471.89). The risk of pneumonia associated with inhaled …

… with an oral corticosteroid and 3 inhaled albuterol and ipratropium treatments. Of 5846 …
Third, while severe PRAM denotes a risk for hospitalization, the subgroup analyses suggest …

… this case series as minimal-risk research using de-identified … nebulized and co-administered
dornase alfa and albuterol (… in intubated patients by endotracheal tube visual inspection. …

… probability that nebulizer treatments may increase the risk of … inhaled corticosteroids and
inhaled bronchodilators [11]. The GOLD strategy also recommends the use of bronchodilators …

… patients requiring inhaled bronchodilators during affection of … of the drugs, especially
albuterol. There also has been … the risk of transmission of infection directly from nebulization …